Statin for Depression in Patients Undergoing Coronary Artery Bypass Graft
Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Depression is frequently observed in patients with coronary heart disease (CHD) and
represents a significant risk factor for major cardiovascular events. Previous study has
proved that high sensitive C-reactive protein (hsCRP) was an independent predictor for
depression in CABG patients at 6 months after bypass surgery. Statins can effectively reduce
the blood levels of hsCRP. This study aim to examine whether statins can improve the
prognosis of depressive patients undergoing coronary artery bypass surgery through reducing
the levels of hsCRP.